BCPC Balchem
Balchem earnings company data as of 4:45 AM ET 10/23
Scheduled
1 period, newest first, nothing reported yet. Each row shows EPS above revenue.
| Period | Date | Metric | Estimate | Actual | Result |
|---|---|---|---|---|---|
| FY2026 Q3 | 23 Oct | EPS | 1.53 | — | — |
| Rev | — | — | — |
Insider trades
Open-market buys and sales by BCPC's executives, directors and 10% owners in the last 12 months, from their Form 4s
- None no insider bought on the open market
- $2.3M sold by 3 insiders outside a trading plan
- None no planned (10b5-1) sales
-
David B Fischer DirectorSale$1.2M 8,000 shares at $153.97 50% of stakeTraded Dec 3, 2025 Filed Dec 5, 2025
-
Job Leonard Van Gunsteren SVP and GM, Specialty ProductsSale$920K 6,000 shares at $153.29 39% of stakeTraded Dec 4, 2025 Filed Dec 5, 2025
-
Martin Luther Reid SVP Chief Supply Chain OfficerSale$185K 1,200 shares at $154.44 14% of stakeTraded Nov 11, 2025 Filed Nov 13, 2025
Also filed in the last 12 months, not counted as buying or selling: 25 share withholdings for taxes, 23 stock grants, and 3 option exercises.
SEC filings
Recent issuer filings from EDGAR, 15 shown.
| Filed | Form | Detail | Links |
|---|---|---|---|
| 8-K | 2.02,9.01 | Filing Doc | |
| 10-Q | Filing Doc | ||
| 8-K | 1.01,2.03,9.01 | Filing Doc | |
| 8-K | 5.07 | Filing Doc | |
| 8-K | 2.02,9.01 | Filing Doc | |
| 10-Q | Filing Doc | ||
| SCHEDULE 13G | — | Filing Doc | |
| SCHEDULE 13G | — | Filing Doc | |
| DEF 14A | Filing Doc | ||
| DEFA14A | Filing Doc | ||
| SCHEDULE 13G/A | — | Filing Doc | |
| 8-K | 2.02,9.01 | Filing Doc | |
| 10-K | Filing Doc | ||
| 8-K | 5.02,9.01 | Filing Doc | |
| 8-K | 7.01,9.01 | Filing Doc |
No filings match this filter.
Estimates are consensus figures; SEC filings remain the official record. Not investment advice.